Latest News

Wondering if Solaris Energy Infrastructure is still a smart buy after its huge run up, or if you are arriving late to the party? We are going to unpack what the current share price really implies about future returns. Even after a sharp pullback of 16.8% over the last week and a modest 2.6% slide over the past month, the stock is still up 56.4% year to date and 67.0% over the last year, capping a 439.8% three year and 540.9% five year run. Those swings have come as investors digest a series...

Owens Corning (OC) just gave income focused investors something to chew on, lifting its quarterly dividend by 15% while doubling down on growth with a new shingle plant in Alabama. See our latest analysis for Owens Corning. Those moves come after a volatile stretch, with the share price down sharply this year but recently stabilising, including a 12.5 percent 1 month share price return and a still respectable 3 year total shareholder return. At a current share price of $116.0, the market...

Wondering if Hormel Foods at around $24 a share is a bargain or a value trap? You are not alone, and this breakdown is designed to give you a clear, no-jargon view. The stock has bounced about 8.0% over the last month after a long slide, with the price still down roughly 23.9% over the past year and more than 40% over five years, which signals a big gap between past expectations and today’s sentiment. That recent rebound has come as investors refocus on Hormel’s portfolio reshaping and cost...

In late 2025, JAC Recruitment completed a share buyback of 300,000 shares, about 0.19% of its outstanding stock, for ¥321.6 million, closing the repurchase plan on November 30. Around the same time, Jefferies began covering JAC Recruitment with a positive view, highlighting the firm’s dual focus on both employers and job candidates as a key differentiator in Japan’s white-collar recruitment market. With Jefferies spotlighting JAC Recruitment’s dual-sided recruitment model, we’ll explore how...

If you are wondering whether ON Semiconductor is quietly turning into a value opportunity, or if the market still sees too much risk in the story, you are not alone. The stock has inched up about 0.4% over the last week and 11.5% over the past month, but it is still down 10.9% year to date and 16.7% over the last year, a reminder that past enthusiasm has cooled even though the 5 year return sits at 74.3%. Recently, investors have been weighing ON Semiconductor's positioning in electric...

GigaCloud Technology stock moves GigaCloud Technology (GCT) has quietly turned into a strong momentum story, with the stock up about 26% over the past month and roughly 35% in the past 3 months. See our latest analysis for GigaCloud Technology. The latest jump takes GigaCloud Technology’s share price to $40.37, with a powerful year to date share price return of around 112 percent and a three year total shareholder return above 600 percent, suggesting momentum is still building as investors...

Why TMC the metals (TMC) Is Back on Traders’ Screens TMC the metals (TMC) has quietly staged a comeback, with the share price up over the past month and past 3 months, even as near term returns remain choppy. See our latest analysis for TMC the metals. That jumpy recent trading sits on top of a huge move, with the share price up sharply on a year to date basis and a 1 year total shareholder return above 700 percent, suggesting momentum is still very much in play even if volatility has picked...

The Lovesac Company recently reported third-quarter fiscal 2026 results showing largely flat net sales at US$150.17 million alongside a wider net loss of US$10.55 million and higher loss per share than a year earlier. Despite weak profitability and below-consensus guidance for the key holiday quarter and full fiscal 2026, management is still investing in product innovation, domestic manufacturing, and marketing to expand its household reach over the long term. We’ll now examine how Lovesac’s...

Star Bulk Carriers (SBLK) has quietly slipped about 11% over the past week, even though its year to date return is still up roughly 18%. That disconnect is where the opportunity becomes interesting for patient, income-focused investors. See our latest analysis for Star Bulk Carriers. That recent 7 day share price return of negative 10.66% looks more like a breather than a breakdown. The stock still sits on a solid year to date share price return of 17.87% and a 5 year total shareholder return...

ACADIA Pharmaceuticals (ACAD) has been quietly rewarding patient investors, with the stock up roughly 57% over the past year and about 45% year to date. This performance reflects growing confidence in its CNS portfolio. See our latest analysis for ACADIA Pharmaceuticals. Zooming out, that strength is not a one week blip. The stock has logged a roughly mid teens 3 month share price return and a standout mid fifties 1 year total shareholder return, suggesting momentum is still building as...

Earlier this week, Barclays initiated coverage on Organon with an “Underweight” rating, adding to a series of cautious analyst views on the pharmaceutical company’s prospects. This accumulation of more skeptical opinions highlights growing concern among Wall Street analysts about Organon’s near-term outlook and the resilience of its key products. We’ll now examine how Barclays’ bearish initiation and the broader shift in analyst sentiment may reshape Organon’s investment narrative. Find...

Efficiency Gains Drive Fresh Attention to Cleveland-Cliffs Cleveland-Cliffs (CLF) is back on investors' radar after Voya MI Dynamic Small Cap Fund spotlighted the stock, crediting efficiency gains in its auto platform and a 12% share jump for boosting portfolio performance. See our latest analysis for Cleveland-Cliffs. That efficiency story has landed on a backdrop of strong momentum, with a roughly 33% year to date share price return to $12.71 even though the five year total shareholder...

Earlier this month, Driven Brands Holdings Inc. updated its 2025 earnings guidance after divesting its international car wash business, now classified as discontinued operations, and projected revenue of US$1.85 billion to US$1.87 billion from continuing operations. This shift sharpens investor focus on the core service portfolio, giving a clearer view of how the remaining businesses are expected to perform financially. Next, we’ll examine how this divestiture-driven guidance update reshapes...

Earlier this week, Mastercard’s board raised its quarterly dividend by 14% to US$0.87 per share and authorized a new US$14.00 billion share repurchase program to follow the completion of its existing US$12.00 billion plan. These larger cash returns, alongside recent partnerships that expand digital payments reach, underline how Mastercard is leaning on strong cash generation to reward shareholders while reinforcing its network. Now we’ll explore how Mastercard’s larger dividend and massive...

Netskope (NTSK) just posted another heavy investing quarter for Q3 2026, with revenue at about $184 million and basic EPS at roughly -$1.85, while trailing 12 month revenue reached about $661 million and EPS sat near -$4.98. The company has seen quarterly revenue move from about $130 million in Q2 2025 to around $184 million in Q3 2026, as EPS shifted from roughly -$1.17 to -$1.85 over the same stretch. This has left investors firmly focused on when this top line traction will start easing...

Carl Zeiss Meditec (XTRA:AFX) has investors’ attention after reporting solid revenue growth for fiscal 2024/25, helped by its Ophthalmology segment and the consolidation of DORC, alongside a constructive outlook for margins. See our latest analysis for Carl Zeiss Meditec. Despite the upbeat revenue and margin outlook, the stock’s 1 year total shareholder return of minus 16.9 percent and 3 year total shareholder return of roughly minus 64.4 percent show that sentiment has been weak. However,...

At its extraordinary general meeting on 12 December 2025, AviChina Industry & Technology approved amendments to its Articles of Association, including abolishing the Supervisory Committee system, and confirmed the appointment of Mr. Gao Jiming as a non-executive director through 2027. This governance overhaul reduces one layer of oversight while reshaping the board, raising fresh questions about how management will now be monitored. We will now examine how the abolition of the Supervisory...

Eastman Chemical (EMN) just quietly extended its dividend growth streak to 16 years, nudging the quarterly payout up to 0.84 dollars while also laying out fresh cost cutting goals for 2026. See our latest analysis for Eastman Chemical. Even with this steady dividend story, Eastman’s 1 year total shareholder return of negative 31.1 percent and weaker year to date share price return suggest momentum has been fading. However, the recent 1 month share price rebound hints sentiment might be...

Medpace Holdings (MEDP) is back in the spotlight after fresh investor letters praised its latest quarter, where revenue climbed about 24% year over year and hefty buybacks amplified earnings power. See our latest analysis for Medpace Holdings. Those strong Q3 numbers and hefty buybacks helped fuel a powerful re-rating, with the share price now at $557.9 and a year-to-date share price return of 66.66%. The five-year total shareholder return of 298.16% shows that momentum, despite a recent...

Leonardo DRS (DRS) is back on investor screens after a flurry of international defense deals, including fresh agreements in Thailand and Saudi Arabia, as well as a new AI driven Counter UAS partnership with Axon Vision. See our latest analysis for Leonardo DRS. Despite this string of international wins, the share price, now at $34.46, has pulled back with a 90 day share price return of minus 18.1 percent. Even though the year to date share price return is still positive and the three year...

Cummins (CMI) just locked in a $500 million contract with the U.S. Army for mobile power generators, a deal that reinforces its core power systems franchise and gives investors a fresh earnings catalyst. See our latest analysis for Cummins. The Army deal lands after a run of upbeat developments, including recent analyst upgrades, and helps extend what has already been a powerful move, with Cummins delivering a roughly mid-20s three-month share price return and a strong triple-digit three-year...

Archer-Daniels-Midland (ADM) just cut its full year outlook, pointing directly to choppy China trade and shifting biofuel policies. That combination has investors rethinking how durable recent earnings strength really is. See our latest analysis for Archer-Daniels-Midland. Even with today’s guidance cut weighing on sentiment, Archer-Daniels-Midland’s roughly 19 percent year to date share price return shows momentum has quietly improved, although the three year total shareholder return still...

Manchester United (MANU) shares have been grinding lower this year, down about 9% year to date and roughly 11% over the past year, leaving investors reassessing how much off pitch performance really matters. See our latest analysis for Manchester United. The recent drift lower, including a 1 day share price return of minus 2.41 percent and a 3 year total shareholder return of minus 29.52 percent, suggests momentum is still fading as investors reassess both growth prospects and ownership...

Mineralys Therapeutics recently announced that its Phase 3 Launch-HTN trial of lorundrostat for uncontrolled or treatment-resistant hypertension was selected for JAMA’s inaugural “Research of the Year Roundup,” highlighting it as one of the most impactful studies published between October 2024 and September 2025. This recognition not only spotlights lorundrostat’s growing clinical profile but also underscores aldosterone’s emerging role as a key therapeutic target in difficult-to-treat...